The application of quantitative cytochemistry to the study of diseases of the connective tissues.
The connective tissues are a complex organisation of tissues, cells and intercellular materials spread throughout the body and are subject to a large number of diseases. Such complexity makes the study of the metabolism of the connective tissues in health and more particularly in disease states difficult if one uses conventional biochemical methodology. Fortunately the techniques of quantitative cytochemistry, as developed in recent years, have made it possible to study the metabolism of even such complex and refractory connective tissues as bone. Using properly validated assays of enzyme activity in unfixed sections from various tissues a number of the diseases of the connective tissues have been studied. For example the synovia from patients with rheumatoid arthritis and related conditions have been studied using these techniques and marked alterations in the metabolism of the synovial lining cell population of this tissue have been demonstrated. These alterations in metabolism are believed to be related to the destruction of cartilage and bone found in such diseases. Investigations of the metabolism of the chondrocytes of articular cartilage in a strain of mice which spontaneously develops osteoarthritis has revealed a lack of certain key enzymes of carbohydrate metabolism in precisely those areas where degradation of the matrix of articular cartilage begins suggesting a causal relationship between these events. These same techniques have been used to study the cellular kinetics and metabolism of the dermis and epidermis in the disfiguring disease, psoriasis. The metabolism of healing bone fractures, the diagnosis and treatment of the mucopolysaccharidoses and the metabolic effects of currently used anti-inflammatory and anti-rheumatic drugs have also been examined. Perhaps the most exciting aspect of these studies has been the development and use of the technique of the cytochemical bioassay (CBA) to study hormonally mediated diseases of the connective tissues. Such studies have recently shed new light on the molecular lesion in pseudohypoparathyroidism. Though still in their relative infancy the studies described in this review show the potential inherent in the use of quantitative cytochemistry for the study of diseases of the connective tissues.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism; D002358:Cartilage, Articular / Q000473:pathology; D002455:Cell Division; D003240:Connective Tissue Diseases / Q000378:metabolism*; D004195:Disease Models, Animal; D000078404:Epidermal Cells; D050723:Fractures, Bone / Q000473:pathology; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006019:Glycolysis; D006600:Hexosephosphates / Q000378:metabolism; D006651:Histocytochemistry / Q000379:methods*; D006801:Humans; D008247:Lysosomes / Q000201:enzymology; D008928:Mitochondria / Q000201:enzymology; D009083:Mucopolysaccharidoses / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D010003:Osteoarthritis / Q000378:metabolism; D011547:Pseudohypoparathyroidism / Q000378:metabolism; D011565:Psoriasis / Q000473:pathology; D013583:Synovial Membrane / Q000378:metabolism; D014812:Vitamin K / Q000627:therapeutic use; D014945:Wound Healing; D015032:Zinc / Q000627:therapeutic use
D006600:Hexosephosphates; D014812:Vitamin K; D009249:NADP; D005954:Glucosephosphate Dehydrogenase; D015032:Zinc